ANRO — ALTO NEUROSCIENCE INC

Ownership history in Squarepoint Ops LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in ALTO NEUROSCIENCE INC (ANRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 22,816 -45,132 -66.4% 0.00% $92K $4.02
2025 Q2 ADDED 67,948 +51,384 +310.2% 0.00% $149K $2.20
2025 Q1 REDUCED 16,564 -11,805 -41.6% 0.00% $36K $2.16
2024 Q1 INITIATED 28,369 — — 0.00% $435K —
% of Fund (quarterly)    ANRO price (monthly, adj. close)

Other funds also holding ANRO

As of 2025 Q4 — sorted by position size

72 Investment Holdings, LLC 3Y 23.5% Alpha Wave Global, LP 3Y 7Y 8.09% Commodore Capital LP 3Y 2.16% Vestal Point Capital, LP 1.5% Vivo Capital, LLC 3Y 7Y 1.19% Ikarian Capital, LLC 3Y 0.72% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.57% AWM Investment Company, Inc. 3Y 7Y 0.39% Integral Health Asset Management, LLC 3Y 0.33% ARMISTICE CAPITAL, LLC 3Y 7Y 0.33%
← Back to Squarepoint Ops LLC Holdings